Evidence map›Paper›PMID 36949901›Full record

ArticleJournal of medical imaging (Bellingham, Wash.)2023

VAI-B: a multicenter platform for the external validation of artificial intelligence algorithms in breast imaging.

Fernando Cossío, Haiko Schurz, Mathias Engström, Carl Barck-Holst, Apostolia Tsirikoglou, Claes Lundström, Håkan Gustafsson, Kevin Smith, Sophia Zackrisson, Fredrik Strand

Full text read
In one paragraph

Article in Journal of medical imaging (Bellingham, Wash.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Fernando CossíoKarolinska Institute, Department of Oncology-Pathology, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-2265-2678
Haiko SchurzKarolinska Institute, Department of Oncology-Pathology, Stockholm, Sweden.
Mathias EngströmCollective Minds Radiology, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-3671-0285
Carl Barck-HolstWest Code Group, Stockholm, Sweden.
Apostolia TsirikoglouKarolinska Institute, Department of Oncology-Pathology, Stockholm, Sweden.
Claes LundströmLinköping University, Center for Medical Image Science and Visualization (CMIV), Linköping, Sweden.
Håkan GustafssonLinköping University, Center for Medical Image Science and Visualization (CMIV), Linköping, Sweden.
Kevin SmithRoyal Institute of Technology (KTH), Division of Computational Science and Technology, Stockholm, Sweden.
Sophia ZackrissonLund University, Department of Diagnostic Radiology, Translational Medicine, Malmö, Sweden.
Fredrik StrandKarolinska Institute, Department of Oncology-Pathology, Stockholm, Sweden.ORCID https://orcid.org/0000-0003-3910-7086

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Multiple vendors are currently offering artificial intelligence (AI) computer-aided systems for triage detection, diagnosis, and risk prediction of breast cancer based on screening mammography. There is an imminent need to establish validation platforms that enable fair and transparent testing of these systems against external data. Approach: We developed validation of artificial intelligence for breast imaging (VAI-B), a platform for independent validation of AI algorithms in breast imaging. The platform is a hybrid solution, with one part implemented in the cloud and another in an on-premises environment at Karolinska Institute. Cloud services provide the flexibility of scaling the computing power during inference time, while secure on-premises clinical data storage preserves their privacy. A MongoDB database and a python package were developed to store and manage the data on-premises. VAI-B requires four data components: radiological images, AI inferences, radiologist assessments, and cancer outcomes. Results: To pilot test VAI-B, we defined a case-control population based on 8080 patients diagnosed with breast cancer and 36,339 healthy women based on the Swedish national quality registry for breast cancer. Images and radiological assessments from more than 100,000 mammography examinations were extracted from hospitals in three regions of Sweden. The images were processed by AI systems from three vendors in a virtual private cloud to produce abnormality scores related to signs of cancer in the images. A total of 105,706 examinations have been processed and stored in the database. Conclusions: We have created a platform that will allow downstream evaluation of AI systems for breast cancer detection, which enables faster development cycles for participating vendors and safer AI adoption for participating hospitals. The platform was designed to be scalable and ready to be expanded should a new vendor want to evaluate their system or should a new hospital wish to obtain an evaluation of different AI systems on their images.

Indexed as

breast cancerdata managementmachine learningmammographyvalidation

Identifiers

PMID36949901
PMCPMC10026999

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read11
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.